These findings indicate that autophagy provides a cytoprotective mechanism in CML cells treated by asparaginase, and inhibition of autophagy may improve the therapeutic efficacy of asparaginase in the treatment of CML. This evidence concerns the gene ASPG and chronic myelogenous leukemia, BCR-ABL1 positive.